Glycated Albumin, a Novel Biomarker for Short-Term Functional Outcomes in Acute Ischemic Stroke
- Supplementary File 1:
PDF-Document (PDF, 214 KiB)
Kim, Y.; Lee, S.-H.; Kang, M.K.; Kim, T.J.; Jeong, H.-Y.; Lee, E.-J.; Bae, J.; Jeon, K.; Nam, K.-W.; Yoon, B.-W. Glycated Albumin, a Novel Biomarker for Short-Term Functional Outcomes in Acute Ischemic Stroke. Brain Sci. 2021, 11, 337. https://doi.org/10.3390/brainsci11030337
Kim Y, Lee S-H, Kang MK, Kim TJ, Jeong H-Y, Lee E-J, Bae J, Jeon K, Nam K-W, Yoon B-W. Glycated Albumin, a Novel Biomarker for Short-Term Functional Outcomes in Acute Ischemic Stroke. Brain Sciences. 2021; 11(3):337. https://doi.org/10.3390/brainsci11030337
Chicago/Turabian StyleKim, Yerim, Sang-Hwa Lee, Min K. Kang, Tae J. Kim, Han-Yeong Jeong, Eung-Joon Lee, Jeonghoon Bae, Kipyoung Jeon, Ki-Woong Nam, and Byung-Woo Yoon. 2021. "Glycated Albumin, a Novel Biomarker for Short-Term Functional Outcomes in Acute Ischemic Stroke" Brain Sciences 11, no. 3: 337. https://doi.org/10.3390/brainsci11030337